Find policies, billing codes, payers, states, and providers
CPT 81377: HLA Class II Allele Group Typing, Low/Intermediate Resolution
CPT code 81377 designates a laboratory technical procedure for low- or intermediate-resolution assessment of human leukocyte antigen (HLA) genes for one Class II antigen equivalent (allele group). This assay supports clinical decisions in transplantation compatibility, immune-mediated disease evaluation, and certain pharmacogenomic contexts, making it a clinically significant molecular diagnostic billed under laboratory services nationally. Coverage and payment for HLA typing affect hospital and outpatient laboratories, transplant programs, and clinical genetic services.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coverage considerations and common billing practices across major national payers, plus context on clinical utility and service settings. The report outlines typical service lines, sites of service, and the technical nature of the assay. It also summarizes common modifiers observed in billing (input provided) and notes when specific payer policy or coding guidance is not available.
This publication helps laboratory administrators, billing professionals, and clinical program leaders understand what CPT code 81377 represents, how it is used in practice, and where to look for payer-specific policy details. Data not available in the input is identified where applicable; the focus remains on national-level clinical and billing context rather than state-specific rules.
Customize your policy alerts
Sign up for cpt 81377 policy alerts
Get alerted when payer policies referencing 81377 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 81377 describes a laboratory technical procedure for low- or intermediate-resolution assessment of human leukocyte antigen (HLA) genes for one Class II antigen equivalent (an allele group of interest). The service is a molecular/genetic laboratory test performed by a laboratory analyst to identify HLA Class II allele groups that may be associated with specific conditions.
Service type: Laboratory — molecular/genetic testing (HLA typing)
Typical site of service: Clinical laboratory or specialized molecular diagnostics laboratory (ambulatory or hospital-based lab setting)